Abiopharma

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

General Announcement::LAPSE OF TERM SHEET IN RELATION TO THE PROPOSED ACQUISITION OF ELPIS BIOPHARMACEUTICALS PTE. LTD

New Form PRE 14A - Akari Therapeutics Plc Filed: 2026-01-22 AccNo: 0001493152-26-003252 Size: 4 MB

Smith+Nephew PLC Notification

New Form 25-NSE - Astria Therapeutics, Inc. Filed: 2026-01-23 AccNo: 0001354457-26-000075 Size: 3 KB

New Form SCHEDULE 13D - AGENUS INC Filed: 2026-01-23 AccNo: 0002106704-26-000001 Size: 13 KB

Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit

BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema

General Announcement: LAPSE OF TERM SHEET IN RELATION TO THE PROPOSED ACQUISITION OF ELPIS BIOPHARMACEUTICALS PTE. LTD.

Lexicon Pharmaceuticals to Ring the Nasdaq Closing Bell on January 27, 2026 to Celebrate 30th Anniversary

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress

Agilent Technologies, Inc. - Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System

Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq

Daxor Corporation Announces $9 Million Registered Direct Offering

Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock